Ko Tanaka
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 7
- Advanced biosensing and bioanalysis techniques 6
- Genetics 4
- Virus-based gene therapy research 4
- Co-authors
- Yuuki Takashima (8 shared papers)Takanori Kanazawa (8 shared papers)Hiroaki Okada (6 shared papers)Tsunehiko Fukuda (3 shared papers)Ken Sugawara (3 shared papers)Takaya Ogawa (3 shared papers)Hiroaki Okada (2 shared papers)Yasuo Seta (1 shared paper)
- Journals
- International Journal of Pharmaceutics (4 papers)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)Veterinary Research Communications (1 paper)Chemical and Pharmaceutical Bulletin (1 paper)Pharmaceutical Research (1 paper)
- Partner nations
- Japan
In The Last Decade
Ko Tanaka
9 papers receiving 367 citations
Peers
Comparison fields: 5 of 54
- Pharmaceutical Science 75
- Biomaterials 122
- Molecular Biology 288
- Microbiology 18
- Cancer Research 36
Countries citing papers authored by Ko Tanaka
This map shows the geographic impact of Ko Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ko Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ko Tanaka more than expected).
Fields of papers citing papers by Ko Tanaka
This network shows the impact of papers produced by Ko Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ko Tanaka. The network helps show where Ko Tanaka may publish in the future.
Co-authors
The 11 scholars most cited alongside Ko Tanaka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 126 | |
| 2 | 2010 | 57 | |
| 3 | 2010 | 54 | |
| 4 | 2012 | 51 | |
| 5 | 2013 | 44 | |
| 6 | 2011 | 24 | |
| 7 | 2011 | 11 | |
| 8 | 2014 | 7 | |
| 9 | 2016 | 3 |
About Ko Tanaka
Ko Tanaka is a scholar working on Molecular Biology, Genetics, Cancer Research, Pharmaceutical Science and Animal Science and Zoology, having authored 9 papers that have together received 377 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (7 papers), Advanced biosensing and bioanalysis techniques (6 papers), Virus-based gene therapy research (4 papers), MicroRNA in disease regulation (3 papers), Animal Virus Infections Studies (1 paper), Immunotherapy and Immune Responses (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and Advanced Drug Delivery Systems (1 paper). The work is most often cited by research in Pharmaceutical Science (75 citations), Biomaterials (122 citations), Molecular Biology (288 citations), Microbiology (18 citations) and Cancer Research (36 citations). Ko Tanaka has collaborated with scholars based in Japan. Frequent co-authors include Yuuki Takashima, Takanori Kanazawa, Hiroaki Okada, Tsunehiko Fukuda, Ken Sugawara, Takaya Ogawa, Hiroaki Okada, Yasuo Seta, Hiroyuki Mizuguchi and Mariko Okamoto. Their work appears in journals such as International Journal of Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics, Veterinary Research Communications, Chemical and Pharmaceutical Bulletin and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.